— Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) reported its third-quarter 2019 adjusted earnings of $6.67 per share versus $6.36 per share expected. — Total revenues grew by 23% to $2.05 billion … Continue reading Regeneron Pharmaceuticals (NASDAQ: REGN): Q3 2019 Earnings Snapshot